Carine Chaleteix

University Hospital, Clermont-Ferrand

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers in multiple myeloma

PubMed author-name match

Trials

Studies that name Carine Chaleteix as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:05 UTC. Open this list on ClinicalTrials.gov

N/A
NCT02976272 · Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple
University Hospital, Clermont-Ferrand · unknown · Multiple Myeloma, Bortezomib Regimen, Adult · principal investigator
Ph1/Ph2
NCT01279694 · Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)
Nantes University Hospital · completed · Myeloma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name in multiple myeloma, ranked by citations from NIH iCite, fetched 2026-11-12 13:05 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed